EcoR1 Capital

Biotechnology · Venture Capital
70investments
28exits
$363.4Mraised by its portfolio in 12 months
188open roles in its portfolio

Overview

EcoR1 Capital is a biotech-focused investment fund that backs companies developing new medicines. It invests in public and private biotechnology companies, including late-stage private rounds, with a science-driven approach centered on clinical-stage drug developers. The firm was founded in 2013 by Oleg Nodelman and is based in San Francisco, California.

Investor profile

Venture capital
Investments
70
21 of them startups
Hiring now
24
188 open roles
Rounds in 12 months
4
$363.4M raised
Exits
28
Focusshare of its companies
Health Care 76%Biotechnology 50%Artificial Intelligence 3%
Where its companies are
United States 37%Greece 1%
Stage of its companies
Series C and later 59%Series B 19%Series A 15%Pre-seed & seed 7%

Visa sponsorship

0
H-1B filings in 12 months
1
Green card filings
$83k
Median offered salary
In the register as EcoR1 Capital LLC., San Francisco, CA
Other sponsors in the same field
Alert me
US Department of Labor · latest filing Feb 10, 2026 · Visa details by country

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Francisco United States
HQ
"The true sign of intelligence is not knowledge but imagination."
10-50 est. staff
357 Tehama Street, Floor 3, San Francisco, CA 94103
company site